Final Program & Abstract Book
Total Page:16
File Type:pdf, Size:1020Kb
Dear colleagues, It’s a great pleasure to invite you to the 6th Congress on Neurobiology, Psychopharmacology and Treatment Guidance which will take place in Chalkidiki, Greece, on June 27-30, 2019. After the great success of the 5th Congress which was held in 2017, this sixth Congress again aims at being valuable for the clinicians who fight daily in the front line for the treatment of real-world patients. In this frame, our goal is to provide a global and comprehensive update of the newest developments in Psychiatry and the allied sciences in a manner, which will be both focused and enriched. The rule is to avoid content-free eloquence and authority and to face hard questions on the base of research findings. Many worldwide experts have been invited to share with us their knowledge and experience once again with the support and guidance of the European Psychiatric Association, the World Psychiatric Association and under the Auspices of the School of Medicine, Aristotle University of Thessaloniki. During these difficult circumstances for the world economy, advanced education and training is the only way to the future. Teaching clinical usefulness and application of new knowledge and informed treatment with psychopharmacological agents in a truly multidisciplinary approach is the central axis of the meeting and although the congress will embrace high tech research concerning psychopathology, new treatment methods, genetics and molecular biology, it also aims on putting the emphasis on the human factor, both the therapist and the patient. Apart from the humanistic tradition of Psychiatry and life sciences, the continuous and unconditional investment on the high level training of professionals and education of patients and their families, emerged as a significant challenge during the last few decades. Medical scientists and public health policy makers are increasingly concerned that the scientific discoveries are failing to be translated efficiently into tangible human benefit. Today, in an all the more complex and technologically advanced environment, the human factor emerges again as the most valuable one, the factor that determines the final outcome. This 6th ICNP specifically focuses on the ultimate aim: that is to empower and eventually free patients and their families from the burden of mental disease and fighting for full remission and functional rehabilitation. It also includes the distinguished aim to spread high-level training to younger generations by including symposia organized by medical students and psychiatric residents from around the world. As hosts and organizers, we shall spare no effort in making your participation scientifically rewarding and meaningful and your stay in Chalkidiki as enjoyable as possible. Konstantinos N. Fountoulakis Professor of Psychiatry, Aristotle University of Thessaloniki, Greece Chair of the 6th International Congress on Neurobiology, Psychopharmacology & Treatment Guidance - ICNP2019 Chair, WPA Section on Pharmakopsychiatry and Section on Evidence-Based Psychiatry 3 The Abbey Library of Saint Gall is a significant medieval monastic library located in St. Gall, Switzerland. In 1983 the library together with the Abbey of St. Gall were designated a World Heritage Site, as “a perfect example of a great Carolingian monastery”. The library was founded by Saint Othmar, founder of the Abbey of St. Gall. During a fire in 937, the Abbey was destroyed, but the library remained intact. The library hall, designed by the ar- chitect Peter Thumb in a Rococo style, was constructed between 1758-67. A Greek inscription above the en- trance door, ΨΥΧΗΣ ΙΑΤΡΕΙΟΝ, trans- lates as "clinic of the soul". The library collection is the oldest in Switzerland, and one of earliest and most important monastic libraries in the world. The library holds almost 160,000 volumes, with most avail- able for public use. In addition to older printed books, the collection includes 1650 incunabula (books printed before 1500), and 2100 manuscripts dating back to the 8th through 15th centuries; among the most notable of the latter are items of Irish, Carolingian, and Ottonian production. These codices are held inside glass cases, each of which is topped by a carved cherub offering a visual clue as to the contents of the shelves below; for instance, the case of astronomy-related materials bears a cherub observing the books through a telescope.[4] Books published before 1900 are to be read in a special read- ing room.[5] The manuscript B of the Nibelungenlied is kept here. A virtual library has been created to provide broader access to the manuscripts: Codices Elec- tronici Sangallenses. Currently, more than 400 manuscripts are available in digital format. 4 Publish your next research article in Annals of General Psychiatry Editor-in-Chief: Prof Konstantinos Fountoulakis (Greece) Reasons to publish in Annals of General Psychiatry • Official journal of the International Society of Neurobiology and Psychopharmacology • High visibility for your work • All articles are open access www.annals-general-psychiatry.com www.biomedcentral.com Main Topics of the Congress The main topics of the congress are the following: • Animal Models • Neuropsychology • Anxiety disorders • Neurophysiology • Basic Neuroscience • Neuropsychobiology • Behavioural disorders • Neuropsychoendocrinology • Bioethics • Non pharmacological biological therapies • Biological rhythms • Nosology and classification • Biomedical Technology • Pharmacogenetics • Childhood and adolescence disorders • Psychiatric Genetics • Clinical Psychiatry • Psychogeriatrics • Clinical Psychopharmacology • Psychoimmunology • Dementia • Psychometrics • Drug development • Psychopharmacology • Eating disorders • Psychophysiology • Evidence-based psychiatry • Psychosocial and other non-biological • Experimental Psychopharmacology therapies and interventions • Forensic Psychiatry • Schizophrenia and other psychotic disorders • Health Economics and Quality of Life • Sexual behaviour and disorders • Information technology and neuroscience • Sleep • Learning abilities and disabilities • Social Psychiatry • Major disaster and mental health • Stress • Memory and cognitive disorders • Substance abuse and dependence • Methodology in Psychiatric research • Suicide • Molecular Psychiatry • Transcultural Psychiatry • Mood disorders • Treatment guidelines • Neural Networks • Violence • Neuroimaging 6 Honorary Chair of the Congress: Bert Sakmann (Germany) Nobel Laureate in Physiology or Medicine 1991 Executive Chair of the Congress: Konstantinos N. Fountoulakis (Greece) Organizing/Scientific Committee & Faculty Agorastos, A. (Greece) Hionidou, Ch. (Greece) Pappa, A. (Greece) Alevizopoulos, G. (Greece) Iakimova, R. (Bulgaria) Pasalidou, Ch. (Greece) Aptalidis, D. (Bulgaria) Ierodiakonou-Benou, I. (Greece) Patsali, M. (Greece) Athanasiadis, L. (Greece) Javed, A. (UK) Penckofer, S. (USA) Athanasiou, M. (Greece) Kalimeris, S. (Greece) Perugi, G. (Italy) Bachetti, M. (Italy) Kaparounaki, Ch. (Greece) Ramnalis, A. (Greece) Balli, P. (Greece) Karakatsoulis, G. (Greece) Rantis, K. (Greece) Batrakouli, V. (Greece) Karanikola, M. (Greece) Rera, E. (Greece) Boksay, I. (USA) Karathanasi, V. (Greece) Rizos, Emm. (Greece) Bonotis, K. (Greece) Karzis, A. (Greece) Samakouri, M. (Greece) Bonti, E. (Greece) Kasper, S. (Austria) Senikidou, G. (Greece) Chatzaki, Aik. (Greece) Konsta, A. (Greece) Sheean, P. (USA) Chrousos, G. (Greece) Krespis, M. (Greece) Skapinakis, P. (Greece) Chumpalova, P. (Bulgaria) Krystal, J. (USA) Sofologi, M. (Greece) Diakaki, K. (Greece) Kympouropoulos, S. (Greece) Soldatos, C. (Greece) Diakogiannis, I. (Greece) Manolopoulou, D.I. (Greece) Sotiropoulou, E. (Greece) Dikeos, D. (Greece) Mavreas, V. (Greece) Stoyanova, M. (Bulgaria) Douzenis, A. (Greece) Möller, H. J. (Germany) Tarazi, F. (USA) Einat, H. (Israel) Moraitou, D. (Greece) Tavormina, G. (Italy) Eleftheriou, N. (Greece) Moretti, P. (Italy) Thanassas, E. (Greece) Erhardt, S. (Sweden) Mousa, D.P. (Greece) Thoma, F. (Greece) Fotiadis, P. (Greece) Nimatoudis, J. (Greece) Touliatos, G. (Greece) Franza, F. (Italy) Ntafouli, M. (Greece) Touloumis, Ch. (Greece) Freund-Levi, Υ. (Sweden) Ntouros, E. (Greece) Tsamakis, K. (Greece) Gatos, Gatopoulos, A. (Greece) Nystazaki, M. (Greece) Tsapakis, E. (Greece) Gavanozis, S. (Greece) Oikonomou, A. (Greece) Tsonis, O. (Greece) Georgiadou, S. (Greece) Panagiotidis, P. (Greece) Tsopelas, Ch. (Greece) Giotakos, O. (Greece) Pandova, M. (Bulgaria) Tzeferakos, G. (Greece) Gonda, X. (Hungary) Papadimitriou, P. (Greece) Venizelos, N. (Sweden) Halaris, A. (USA) Papadopoulou, E. (Greece) Heinz, E. (Greece) Papadopoulou, K. (Greece) Henry, M. (USA) Paparrigopoulos, Th. (Greece) 7 Dr. Judd was one of a generation of prominent psychiatrists who came to believe that the work of Freud and Jung, on which they had trained, was more art than science. Biology and genetics were the way forward, they argued, and Dr. Judd was in the right place at the right time to help make that happen. His work as head of the NIMH helped put in place the so-called Decade of the Brain, an ambitious research agenda focused on brain biology as the key to understanding and treating psychiatric problems. In 1987, after helping to build the U.C. San Diego psychiatry department into a leader in re- search, he was chosen to take over the National Institute of Mental Health in Bethesda, Md., the world’s largest source of funding for brain and behavior research. Lewis Lund Judd was born in Los Angeles on Feb. 10, 1930, the first of two sons of